United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 28, 2026 · Filed Apr 29, 2026

On Apr 28, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$568.04 for US$5.4M under a trading plan, leaving 40,513 shares. Filed Apr 29, 2026 (Form 4).

Sold
9,500 shares
Price
US$568.04 average (US$565.18 to US$571.79)
Value
US$5.4M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 28, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 28, 2026Common StockSale239US$565.1849,774Direct
Apr 28, 2026Common StockSale1,598US$566.1448,176Direct
Apr 28, 2026Common StockSale1,489US$567.0146,687Direct
Apr 28, 2026Common StockSale3,123US$568.0743,564Direct
Apr 28, 2026Common StockSale1,531US$568.9342,033Direct
Apr 28, 2026Common StockSale926US$569.8841,107Direct
Apr 28, 2026Common StockSale228US$571.0840,879Direct
Apr 28, 2026Common StockSale366US$571.7940,513Direct

Source

View original at SEC

Related